Table 9 Net budget impact due to adoption of epoetin SEBs for years 1 to 5, and cumulative impact over 5 years
Year | Total drug cost in without SEB scenario ($) | Total drug cost in SEB scenario ($) | Net budget impact ($) |
|---|---|---|---|
Year 1 | 262,665,144 | 228,045,878 | −34,619,266 |
Year 2 | 293,803,997 | 253,494,088 | −40,309,908 |
Year 3 | 317,499,168 | 272,223,786 | −45,275,381 |
Year 4 | 330,514,535 | 281,003,457 | −49,511,077 |
Year 5 | 329,951,320 | 278,742,875 | −51,208,445 |
Cumulative total | 1,534,434,163 | 1,313,510,085 | −220,924,078 |